Cargando…
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged in Wuhan in December 2019 and has since spread across the world. Even though the majority of patients remain completely asymptomatic, some develop severe systemic complications. In...
Autores principales: | Ruetsch, Caroline, Brglez, Vesna, Crémoni, Marion, Zorzi, Kévin, Fernandez, Céline, Boyer-Suavet, Sonia, Benzaken, Sylvia, Demonchy, Elisa, Risso, Karine, Courjon, Johan, Cua, Eric, Ichai, Carole, Dellamonica, Jean, Passeron, Thierry, Seitz-Polski, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873370/ https://www.ncbi.nlm.nih.gov/pubmed/33585507 http://dx.doi.org/10.3389/fmed.2020.603961 |
Ejemplares similares
-
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021) -
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
por: Cremoni, Marion, et al.
Publicado: (2020) -
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021) -
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022) -
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)